Finding the right route for insulin delivery - an overview of implantable pump therapy.

Finding the right route for insulin delivery - an overview of implantable pump therapy.
复制标题

DOI:
10.1080/17425247.2017.1267138
复制
发表时间:
2017-09
影响因子:
6.6
通讯作者:
Hovorka R
Hovorka R
中科院分区:
医学2区
文献类型:
--
作者:
Bally L;Thabit H;Hovorka R

文献摘要

参考文献

被引文献

相似文献

采用腹膜内胰岛素递送途径的植入式泵治疗在过去三十年中已经可用。植入式胰岛素泵治疗的关键原理是恢复正常生理的门静脉-外周胰岛素梯度。临床实践中的吸收仅限于专业中心和选定的患者人群。植入泵治疗进行了讨论,包括技术方面,其使用的理由,血糖和非血糖的影响。重点介绍了目标人群、临床研究总结和植入式泵治疗相关问题。最后指出了植入式泵治疗的局限性及其在临床应用中的前景。虽然腹膜内胰岛素给药似乎更接近正常生理学,但技术、药理学和成本障碍阻止了更广泛的采用。来自临床研究的证据仍然很少且不确定。因此,植入式胰岛素泵治疗的使用将仅限于少数人群,除非取得了相当大的技术进步,并且进行良好的研究可以证明血糖和/或非血糖获益,证明更广泛的应用是合理的。
Implantable pump therapy adopting the intraperitoneal route of insulin delivery has been available for the past three decades. The key rationale for implantable pump therapy is the restoration of the portal-peripheral insulin gradient of the normal physiology. Uptake in clinical practice is limited to specialized centers and selected patient populations. Implantable pump therapy is discussed, including technical aspects, rationale for its use, and glycemic and non-glycemic effects. Target populations, summaries of clinical studies and issues related to implantable pump therapy are highlighted. Limitations of implantable pump therapy and its future outlook in clinical practice are presented. Although intraperitoneal insulin delivery appears closer to the normal physiology, technical, pharmacological, and costs barriers prevent a wider adoption. Evidence from clinical studies remains scarce and inconclusive. As a consequence, the use of implantable pump therapy will be confined to a small population unless considerable technological progress is made and well-conducted studies can demonstrate glycemic and/or non-glycemic benefits justifying wider application.
DOI: 10.1055/s-2007-1009144
发表时间: 1989-01-01
影响因子: 2.2
作者:
COLETTE, C;PARESHERBUTE, N;MIROUZE, J
通讯作者: MIROUZE, J
DOI: 10.1172/jci27073
发表时间: 2006-02-01
影响因子: 15.9
作者:
Edgerton, DS;Lautz, M;Cherrington, AD
通讯作者: Cherrington, AD
DOI: 10.1007/s00423-008-0437-9
发表时间: 2010-01-01
影响因子: 2.3
作者:
Haveman, Jan Willem;Logtenberg, Susan J. J.;Blomme, Adri M.
通讯作者: Blomme, Adri M.
DOI: 10.1172/jci108047
发表时间: 1975-01-01
影响因子: 15.9
作者:
HORWITZ, DL;STARR, JI;RUBENSTEIN, AH
通讯作者: RUBENSTEIN, AH
DOI: 10.2337/diacare.25.1.84
发表时间: 2002-01-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Jeandidier, N;Boullu, S;Pinget, M
通讯作者: Pinget, M